News & Updates

The administration of restrictive, compared with standard, intravenous (IV) fluid therapy to patients with septic shock in the intensive care unit (ICU) did not result in a reduction in mortality risk, according to results of the CLASSIC* trial.

Treatment with amantadine appears to lower mortality among COVID-19 patients with severe respiratory failure in the intensive care unit (ICU), a retrospective study has found.

The use of multiple-dose antibiotic to prevent surgical site infection and implant removal following implant-based breast reconstruction does not appear to be more effective than a single-dose regimen, as shown in a study. In addition, the multi-dose regimen increases the risk of adverse events associated with antibiotic treatment.

Children with pre-existing inborn errors of immunity are at greater risk of death when infected with the SARS-CoV-2 virus, according to a new study.